• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Nonbeneficial treatment and conflict resolution: building consensus.非有益治疗与冲突解决:建立共识
Perm J. 2013 Summer;17(3):23-7. doi: 10.7812/TPP/12-124.
2
The costs of nonbeneficial treatment in the intensive care setting.重症监护环境下非有益治疗的成本。
Health Aff (Millwood). 2005 Jul-Aug;24(4):961-71. doi: 10.1377/hlthaff.24.4.961.
3
Defining futile life-prolonging treatments through Neo-Socratic Dialogue.通过新苏克拉底式对话来定义无益的延长生命的治疗。
BMC Med Ethics. 2013 Dec 9;14:51. doi: 10.1186/1472-6939-14-51.
4
Nonbeneficial or futile medical treatment: conflict resolution guidelines for the San Francisco Bay area. Bay Area Network of Ethics Committees (BANEC) Nonbeneficial Treatment Working Group.无益或无效的医学治疗:旧金山湾区的冲突解决指南。湾区伦理委员会网络(BANEC)无益治疗工作组。
West J Med. 1999 May;170(5):287-90.
5
Nonbeneficial treatment Canada: definitions, causes, and potential solutions from the perspective of healthcare practitioners*.无益治疗加拿大:医疗保健从业者视角下的定义、原因及潜在解决方案*。
Crit Care Med. 2015 Feb;43(2):270-81. doi: 10.1097/CCM.0000000000000704.
6
"Do everything!" Encountering "futility" in medical practice.“竭尽所能!”——在医疗实践中遭遇“医疗无意义”。
Ethics Med. 2003 Summer;19(2):103-13.
7
Effect of ethics consultations on nonbeneficial life-sustaining treatments in the intensive care setting: a randomized controlled trial.伦理咨询对重症监护环境中无意义生命维持治疗的影响:一项随机对照试验。
JAMA. 2003 Sep 3;290(9):1166-72. doi: 10.1001/jama.290.9.1166.
8
Erring on the side of Theresa Schiavo: reflections of the special guardian ad litem.偏向特丽萨·夏沃一方:诉讼监护人的思考
Hastings Cent Rep. 2005 May-Jun;35(3):16-9.
9
Decisions to limit or continue life-sustaining treatment by critical care physicians in the United States: conflicts between physicians' practices and patients' wishes.美国重症监护医师关于限制或继续维持生命治疗的决策:医师的做法与患者意愿之间的冲突。
Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):288-92. doi: 10.1164/ajrccm.151.2.7842181.
10
Reflections on the Golubchuk case.对戈卢布丘克案的反思。
Am J Bioeth. 2010 Mar;10(3):73-4. doi: 10.1080/15265161003708425.

引用本文的文献

1
Hospital Planning for Contingency and Crisis Conditions: Crisis Standards of Care Lessons from COVID-19.针对突发事件和危机情况的医院规划:来自COVID-19的危机护理标准经验教训
Jt Comm J Qual Patient Saf. 2022 Jun-Jul;48(6-7):354-361. doi: 10.1016/j.jcjq.2022.02.003. Epub 2022 Feb 10.
2
Entrustment in physician-patient communication: a modified Delphi study using the EPA approach.委托在医患沟通中的作用:采用 EPA 方法的改良德尔菲研究。
BMC Med Educ. 2021 Sep 20;21(1):497. doi: 10.1186/s12909-021-02931-1.
3
Pain Management in a Terminally Ill Patient with a Surrogate Decision-maker: A Challenge.在有替代决策者的晚期患者中进行疼痛管理:一项挑战。
Cureus. 2019 Aug 19;11(8):e5429. doi: 10.7759/cureus.5429.

本文引用的文献

1
Living with advanced illness: longitudinal study of patient, family, and caregiver needs.与晚期疾病共存:对患者、家庭和护理人员需求的纵向研究。
Perm J. 2012 Summer;16(3):28-35. doi: 10.7812/tpp/12-029.
2
The familiar foundation and the fuller sense: ethics consultation and narrative.熟悉的基础与更丰富的意义:伦理咨询与叙事
Perm J. 2012 Spring;16(2):60-3. doi: 10.7812/TPP/11-150.
3
Of goals and goods and floundering about: a dissensus report on clinical ethics consultation.关于目标、利益与挣扎:一份关于临床伦理咨询的意见分歧报告
HEC Forum. 2009 Sep;21(3):275-91. doi: 10.1007/s10730-009-9101-1.
4
Using qualitative methods to explore key questions in palliative care.运用定性方法探究姑息治疗中的关键问题。
J Palliat Med. 2009 Aug;12(8):725-30. doi: 10.1089/jpm.2009.9580.
5
Futility, conscientious refusal, and who gets to decide.无效治疗、良心拒绝以及由谁来做决定
J Med Philos. 2008 Aug;33(4):356-73. doi: 10.1093/jmp/jhn019.
6
Fair and just culture, team behavior, and leadership engagement: The tools to achieve high reliability.公平公正文化、团队行为与领导力参与:实现高可靠性的工具。
Health Serv Res. 2006 Aug;41(4 Pt 2):1690-709. doi: 10.1111/j.1475-6773.2006.00572.x.
7
Precedent autonomy and subsequent consent.
Ethical Theory Moral Pract. 2004 Jun;7(3):267-91. doi: 10.1023/b:etta.0000042908.13784.00.
8
Conscientious refusal and a doctors's right to quit.良心拒绝与医生的辞职权。
J Med Philos. 2004 Feb;29(1):75-91. doi: 10.1076/jmep.29.1.75.30410.
9
Informed consent: does it take a village? The problem of culture and truth telling.
Camb Q Healthc Ethics. 2001 Winter;10(1):34-46. doi: 10.1017/s0963180101001050.

非有益治疗与冲突解决:建立共识

Nonbeneficial treatment and conflict resolution: building consensus.

作者信息

Nelson Craig M, Nazareth Blanca Arriola

机构信息

Director of Medical Bioethics at the South Bay Medical Center in Harbor City, CA. E-mail:

出版信息

Perm J. 2013 Summer;17(3):23-7. doi: 10.7812/TPP/12-124.

DOI:10.7812/TPP/12-124
PMID:24355887
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3783073/
Abstract

INTRODUCTION

We established a fair and explicit nonbeneficial treatment and conflict resolution policy at our medical center. The policy was designed to help us acknowledge and respect both patients and clinicians involved in treatment planning and decision making.

OBJECTIVE

To qualitatively describe how our hospitalwide nonbeneficial treatment and conflict resolution policy was used.

DESIGN

Retrospective evaluation of all bioethics consultations from November 6, 2009, when the policy was adopted, through August 6, 2012. Case-specific data were obtained when nonconsensus occurred involving withholding or withdrawing of nonbeneficial treatment.

MAIN OUTCOME MEASURES

Rates of resolution of conflicts and treatment plan consensus when nonbeneficial treatment was withheld or withdrawn.

RESULTS

We identified 146 (39.4%) cases where there was a treatment-level conflict between patients/surrogates and the treatment teams responsible for their care. In 54 (37.0%) of the cases, resolution occurred. In 92 (63.0%) of the cases, nonbeneficial treatment was eventually withheld or withdrawn. In 87 (94.6%) of the cases where treatment was withheld or withdrawn, the treatment teams and patients/surrogates reached consensus by the conclusion of the bioethics consultation process using the fair and explicit nonbeneficial treatment and conflict resolution policy.

CONCLUSION

A fair and explicit nonbeneficial treatment and conflict resolution policy can result in a high level of consensus between patients/surrogates and the treatment teams responsible for their care when treatment is withheld or withdrawn.

摘要

引言

我们在医疗中心制定了一项公平且明确的无益处治疗及冲突解决政策。该政策旨在帮助我们承认并尊重参与治疗规划和决策的患者及临床医生。

目的

定性描述我们全院范围的无益处治疗及冲突解决政策是如何被运用的。

设计

对2009年11月6日(该政策采用之日)至2012年8月6日期间所有生物伦理咨询进行回顾性评估。当在涉及放弃或撤销无益处治疗出现意见不一致时获取具体病例数据。

主要观察指标

当放弃或撤销无益处治疗时冲突的解决率及治疗计划的共识率。

结果

我们确定了146例(39.4%)患者/代理人与负责其治疗的医疗团队之间存在治疗层面冲突的病例。其中54例(37.0%)冲突得到解决。92例(63.0%)最终放弃或撤销了无益处治疗。在87例(94.6%)放弃或撤销治疗的病例中,通过运用公平且明确的无益处治疗及冲突解决政策,医疗团队与患者/代理人在生物伦理咨询过程结束时达成了共识。

结论

一项公平且明确的无益处治疗及冲突解决政策能够在放弃或撤销治疗时,使患者/代理人与负责其治疗的医疗团队之间达成高度共识。